Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.
Sontake, V; Kasam, RK; Sinner, D; Korfhagen, TR; Reddy, GB; White, ES; Jegga, AG; Madala, SK.
JCI insight.
2018;
3.
Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
Wang, Y; Yella, J; Chen, J; McCormack, FX; Madala, SK; Jegga, AG.
BMC Pulmonary Medicine.
2017;
17.
Repetitive intradermal bleomycin injections evoke T-helper cell 2 cytokine-driven pulmonary fibrosis.
Singh, B; Kasam, RK; Sontake, V; Wynn, TA; Madala, SK.
American Journal of Physiology: Lung Cellular and Molecular Physiology.
2017;
313:L796-L806.
Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake, V; Wang, Y; Kasam, RK; Sinner, D; Reddy, GB; Naren, AP; McCormack, FX; White, ES; Jegga, AG; Madala, SK.
JCI insight.
2017;
2.
Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.
Madala, SK; Sontake, V; Edukulla, R; Davidson, CR; Schmidt, S; Hardie, WD.
American Journal of Respiratory Cell and Molecular Biology.
2016;
55:792-803.
IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function.
Singh, B; Jegga, AG; Shanmukhappa, KS; Edukulla, R; Khurana, GH; Medvedovic, M; Dillon, SR; Madala, SK.
PLoS ONE.
2016;
11:e0161877-e0161877.
Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.
Sontake, V; Shanmukhappa, SK; DiPasquale, BA; Reddy, GB; Medvedovic, M; Hardie, WD; White, ES; Madala, SK.
Journal of immunology (Baltimore, Md. : 1950).
2015;
195:3978-3991.
Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression.
Edukulla, R; Singh, B; Jegga, AG; Sontake, V; Dillon, SR; Madala, SK.
The Journal of biological chemistry.
2015;
290:13510-13520.
Bone Marrow-Derived Stromal Cells Are Invasive and Hyperproliferative and Alter Transforming Growth Factor-alpha-Induced Pulmonary Fibrosis.
Madala, SK; Edukulla, R; Schmidt, S; Davidson, C; Ikegami, M; Hardie, WD.
American Journal of Respiratory Cell and Molecular Biology.
2014;
50:777-786.
Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis.
Madala, SK; Edukulla, R; Phatak, M; Schmidt, S; Davidson, C; Acciani, TH; Korfhagen, TR; Medvedovic, M; LeCras, TD; Wagner, K; et al.
PLoS ONE.
2014;
9:e86536-e86536.